Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Prevention Epicenters Publications and Findings

Bloodstream Infections

  1. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013 Jun 13;368(24):2255-65.
  2. Caroff DA, Norris AH, Keller S, Vinnard C, Zeitler KE, Lukaszewicz J, Zborowski KA, Linkin DR; CDC Prevention Epicenters Program. Catheter salvage in home infusion patients with central line-associated bloodstream infection. Am J Infect Control. 2014 Dec;42(12):1331-3.
  3. Mayer J, Greene T, Howell J, Ying J, Rubin MA, Trick WE, Samore MH; CDC Prevention Epicenters Program. Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis. 2012 Aug;55(3):364-70.
  4. Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP; CDC Prevention Epicenters Program. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clin Infect Dis. 2012 Jun;54(12):1692-8.
  5. Hota B, Harting B, Weinstein RA, Lyles RD, Bleasdale SC, Trick W; Centers for Disease Control and Prevention Epicenters. Electronic algorithmic prediction of central vascular catheter use. Infect Control Hosp Epidemiol. 2010 Jan;31(1):4-11.
  6. Kidd KM, Sinkowitz-Cochran RL, Giblin TB, Tokars JI, Cardo DM, Solomon SL; Prevention Epicenters Program. Barriers to and facilitators of implementing an intervention to reduce the incidence of catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 2007 Jan;28(1):103-5.
  7. Climo M, Diekema D, Warren DK, Herwaldt LA, Perl TM, Peterson L, Plaskett T, Price C, Sepkowitz K, Solomon S, Tokars J, Fraser VJ, Wong E (2003, December). Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infection Control and Hospital Epidemiology, 24(12):942-5.
  8. Diekema DJ, Lee K, Raney P, Herwaldt LA, Doern GV, and Tenover FC (2004. Accuracy and Appropriateness of Antimicrobial Susceptibility Test Reporting for Bacteria Isolated from Blood Cultures. Journal of Clinical Microbiology, 42:2258-2260. DOI: 10.1128/JCM.42.5.2258-2260.2004.
  9. Lin MY, Weinstein RA, Hota B (2008). Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrobial Agents Chemotherapy, 52(9):3188-94.

Clostridium difficile Infection

  1. Caroff DA, Edelstein PH, Hamilton K, Pegues DA; CDC Prevention Epicenters Program. The Bristol stool scale and its relationship to Clostridium difficile infection. J Clin Microbiol. 2014 Sep;52(9):3437-9.
  2. Kasper AM, Nyazee HA, Yokoe DS, Mayer J, Mangino JE, Khan YM, Hota B, Fraser VJ, Dubberke ER; Centers for Disease Control and Prevention Epicenters Program. A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol. 2012 May;33(5):470-6.
  3. Dubberke ER, Butler AM, Nyazee HA, Reske KA, Yokoe DS, Mayer J, Mangino JE, Khan YM, Fraser VJ; Centers for Disease Control and Prevention Epicenters Program. The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis. 2011 Jul 1;53(1):20-5.
  4. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, Khan YM, Popovich KJ, Stevenson KB, McDonald LC, Olsen MA, Fraser VJ; Prevention Epicenters Program of the Centers for Disease Control and Prevention. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol. 2010 Mar;31(3):262-8.
  5. Dubberke ER, Butler AM, Hota B, Khan YM, Mangino JE, Mayer J, Popovich KJ, Stevenson KB, Yokoe DS, McDonald LC, Jernigan J, Fraser VJ; Prevention Epicenters Program from the Centers for Disease Control and Prevention. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009 Jun;30(6):518-25.
  6. Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, D’Angelo G, McDonald LC, Fraser VJ (2008). Attributable Outcomes of Endemic Clostridium difficile-associated Disease in Nonsurgical Patients. Emerging Infectious Diseases, 14 (7):1031-8.
  7. Dubberke E, Butler A, Hota B, Khan Y, Mangino J, Mayer J, Popovich K, Stevenson K, Yokoe D, McDonald C, Jernigan J, Fraser V (2009). Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for Clostridium difficile infection. Infection Control and Hospital Epidemiology, 30(6):518-25.
  8. Litvin M, Reske K, Mayfield J, McMullen K, Georgantopoulos P, Copper S, Hoppe-Bauer J, Fraser V, Warren D, Dubberke E (2009). Identification of a Pseudo-Outbreak of Clostridium difficile Infection (CDI) and the Effect of Repeated Testing, Sensitivity, and Specificity on Perceived Prevalence of CDI. Infection Control and Hospital Epidemiology, 20:1166-1171.
  9. Dubberke E, McMullen K, Mayfield J, Reske K, Georgantopoulos P, Warren D, Fraser V (2009). Hospital-associated Clostridium difficile Infection: Is It Necessary to Track Community-Onset Disease? Infection Control and Hospital Epidemiology, 30:332-
  10. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ (2008). Short and Long-Term Attributable Costs of Clostridium difficile-associated Disease in Nonsurgical Inpatients. Clinical Infectious Diseases, 46:497-504. DOI: 10.1086/526530.
  11. Dubberke ER, Wertheimer AI (2009). Review of Current Literature on the Economic Burden of Clostridium difficile Infection. Infection Control and Hospital Epidemiology, 30(1):57–66.
  12. Sohn S, Climo M, Diekema D, Fraser V, Herwaldt L, Marino S, Noskin G, Perl T, Song X, Tokars J, Warren D, Wong E, Yokoe DS, Zembower T, Sepkowitz KA, and Prevention Epicenter Hospitals. (2005, August). Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infection Control and Hospital Epidemiology, 26(8):676-9.

Use of Chlorhexidine Bathing to Prevent Healthcare-associated Infections

  1. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013 Jun 13;368(24):2255-65.
  2. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, and Weinstein RA (2007). Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Archives of Internal Medicine, 167(19):2073-9.
  3. Climo MW, Septowitz KA, Zucotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES (2009). The Effect of daily bathing with Chlorhexidine on the Acquisition of Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci and Healthcare-associated Bloodstream Infections: Results of a Quasi-experimental Multicenter Trial. Critical Care Medicine, 37(6):1858-65.
  4. Popovich K, Hota B, Hayes R, Weinstein R, Hayden M (2009). Effectiveness of routine Patient Cleansing with Chlorhexidine Gluconate for Infection Prevention in the Medical Intensive Care Unit. Infection Control and Hospital Epidemiology, 30(10):959-963.

Methicillin-resistant Staphylococcus aureus, Carbapenem-resistant Enterobacteriacaeae, and other Resistant Organisms

  1. Hayden MK, Lin MY, Lolans K, Weiner S, Blom D, Moore NM, Fogg L, Henry D, Lyles R, Thurlow C, Sikka M, Hines D, Weinstein RA; Centers for Disease Control and Prevention Epicenters Program. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis. 2015 Apr 15;60(8):1153-61.
  2. Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots C, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program. Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli. Antimicrob Agents Chemother. 2014 Nov;58(11):7003-6.
  3. Knelson LP, Williams DA, Gergen MF, Rutala WA, Weber DJ, Sexton DJ, Anderson DJ; Centers for Disease Control and Prevention Epicenters Program. A comparison of environmental contamination by patients infected or colonized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a multicenter study. Infect Control Hosp Epidemiol. 2014 Jul;35(7):872-5.
  4. Calderwood MS, Desjardins CA, Sakoulas G, Nicol R, Dubois A, Delaney ML, Kleinman K, Cosimi LA, Feldgarden M, Onderdonk AB, Birren BW, Platt R, Huang SS; CDC Prevention Epicenters Program. Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus. J Infect Dis. 2014 Feb 15;209(4):571-7.
  5. Khair HN, VanTassell P, Henderson JP, Warren DK, Marschall J; CDC Prevention Epicenters Program. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria. J Hosp Infect. 2013 Nov;85(3):183-8.
  6. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, Trick WE, Weinstein RA, Hayden MK; Centers for Disease Control and Prevention Epicenters Program. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013 Nov;57(9):1246-52.
  7. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013 Jun 13;368(24):2255-65.
  8. Prabaker K, Lin MY, McNally M, Cherabuddi K, Ahmed S, Norris A, Lolans K, Odeh R, Chundi V, Weinstein RA, Hayden MK; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumonia carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol. 2012 Dec;33(12):1193-9.
  9. Hota B, Lyles R, Rim J, Popovich KJ, Rice T, Aroutcheva A, Weinstein RA; CDC Prevention Epicenters. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clin Infect Dis. 2011 Oct;53(8):757-65.
  10. Climo M, Sepkowitz K, Zuccotti G, Fraser V, Warren D, Perl T, Speck K, Jernigan J, Bush A, Wong E (2009). Daily Bathing with Chlorhexidine Reduces the Acquisition of Methicillin- resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and Healthcare- associated Bloodstream Infections: Results of a Multicenter Trial. Critical Care Medicine, 37(6):1858-65
  11. Data R, Huang, SS (2008). Risk of Infection and Death due to Methicillin-resistant Staphylococcus aureus in Long-term Carriers. Clinical Infectious Diseases, 47(2):176-81.
  12. Evans RS, Wallace CJ, Lloyd JF, Taylor CW, Abouzelof RH, Sumner S, Johnson KW, Wuthrich A, Harbarth S, Samore MH (2008). Rapid Identification of Hospitalized Patients at High Risk for MRSA Carriage. Journal of the American Medical Informatics Association, 15(4): 506-512. DOI:10.1197/jamia.M2721.
  13. Hota B, Ellenbogen C, Hayden M, Aroutcheva A, Rice T, Weinstein R (2007). Community associated Methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Archives of Internal Medicine, 167(10): 1026-33.
  14. Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, Cosgrove SE, Perl TM, Pottinger JM, Herwaldt LA, Jernigan JA, Tokars JL, Diekema DJ, Hinrichsen VL, Yokoe DS, Platt R (2007, February). Improving Methicillin-resistant Staphylococcus aureus Surveillance and Reporting in Intensive Care Units. Journal of Infectious Diseases, 195(3):330-8.
  15. Huang SS, Platt R (2003, February). Risk of Methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Journal of Clinical Infectious Diseases, 36(3):281-5.
  16. Huang SS, Diekema D, Warren D, Zuccotti G, Winokur P, Tendolkar S, Ward M, Datta R, Jones R, Boyken L, Aubrey T, Onderdone A, Platt R (2008). Strain-relatedness of Methicillin-resistant Staphylococcus aureus isolates from patients with repeated infection. Clinical Infectious Diseases, 46(8):1241-7.
  17. McMullen K, Warren D, Woeltje K (2009). The Changing Susceptibilities of Methicillin-resistant Staphylococcus aureusat a Midwestern Hospital: The Emergence of “Community- Associated” MRSA. American Journal of Infection Control, 37(6):454-7.
  18. Popovich K (2009). Staphylococcus aureus: Not Always Right Under Your Nose. Infection Control and Hospital Epidemiology, 30(8):272-729.
  19. Popovich K, Hota B (2008). The Treatment and Prevention of Community-associated methicilin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Dermatological Therapy, 21(3):167-79, 1396-0296.
  20. Popovich K, Hota B, Weinstein R (2008). Treatment of Community-associated Methicillin-resistant Staphylococcus aureus. Current Infection Diseases, 9(5):398-407. Current Infectious Disease Report, 10(5):411-20.
  21. Popvich K, Hota B, Rice T, Aroutcheva A, Weinstein R (2007). Phenotypic Prediction Rule for Community-associated Methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology, 45(7) :2293-5.
  22. Popovich K, Weinstein R (2009). The Graying of Methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology, 30(1):9-12.
  23. Popovich KJ, Weinstein RA, and Hota B (2008). Are community-associated Methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clinical Infectious Diseases, 46(6):787-94.
  24. Huang SS, Rifas-Shiman SL, Pottinger JM, Herwaldt LA, Zembower TR, Noskin GA, Cosgrove SE, Perl TM, Curtis AB, Tokars JL, Diekema DJ, Jernigan JA, Hinrichsen VL, Yokoe DS, Platt R; Centers for Disease Control and Prevention Epicenters Program. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis. 2007 Feb 1;195(3):339-46.

Sepsis

  1. Rhee C, Murphy MV, Li L, Platt R, Klompas M; Centers for Disease Control and Prevention Epicenters Program. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study. Crit Care. 2015 Sep 14;19(1):338.
  2. Rhee C, Murphy MV, Li L, Platt R, Klompas M; Centers for Disease Control and Prevention Prevention Epicenters Program. Lactate Testing in Suspected Sepsis: Trends and Predictors of Failure to Measure Levels. Crit Care Med. 2015 Aug;43(8):1669-76.
  3. Rhee C, Murphy MV, Li L, Platt R, Klompas M; Centers for Disease Control and Prevention Epicenters Program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis. 2015 Jan 1;60(1):88-95.

Surgical Site Infections

  1. Rhee C, Huang SS, Berríos-Torres SI, Kaganov R, Bruce C, Lankiewicz J, Platt R, Yokoe DS; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Surgical site infection surveillance following ambulatory surgery. Infect Control Hosp Epidemiol. 2015 Feb;36(2):225-8.
  2. Calderwood MS, Kleinman K, Bratzler DW, Ma A, Kaganov RE, Bruce CB, Balaconis EC, Canning C, Platt R, Huang SS; CDC Prevention Epicenters Program; Oklahoma Foundation for Medical Quality. Medicare claims can be used to identify US hospitals with higher rates of surgical site infection following vascular surgery. Med Care. 2014 Oct;52(10):918-25.
  3. Calderwood MS, Kleinman K, Bratzler DW, Ma A, Bruce CB, Kaganov RE, Canning C, Platt R, Huang SS; Centers for Disease Control and Prevention Epicenters Program; Oklahoma Foundation for Medical Quality. Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty. Infect Control Hosp Epidemiol. 2013 Jan;34(1):31-9.
  4. Yokoe DS, Khan Y, Olsen MA, Hooper DC, Greenbaum M, Vostok J, Lankiewicz J, Fraser VJ, Stevenson KB; Centers for Disease Control and Prevention Epicenters Program. Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery. Infect Control Hosp Epidemiol. 2012 Aug;33(8):768-73.
  5. Calderwood MS, Ma A, Khan YM, Olsen MA, Bratzler DW, Yokoe DS, Hooper DC, Stevenson K, Fraser VJ, Platt R, Huang SS; CDC Prevention Epicenters Program. Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol. 2012 Jan;33(1):40-9.
  6. Bolon MK, Hooper D, Stevenson KB, Greenbaum M, Olsen MA, Herwaldt L, Noskin GA, Fraser VJ, Climo M, Khan Y, Vostok J, Yokoe DS; Centers for Disease Control and Prevention Epicenters Program. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis. 2009 May 1;48(9):1223-9.
  7. Apisarnthanarak A, Jones M, Waterman BM, Carroll CM, Bernardi R, Fraser VJ (2003). Risk factors for spinal surgical site infections in a community hospital: A case-control study. Infection Control and Hospital Epidemiology, 24:31-6. DOI: 10.1086/502197
  8. Bolon M, Hooper D, Stevenson K, Greenbaum M, Olsen M, Platt R, Herwaldt L, Noskin G, Fraser V, Climo M, Khan Y, Vostok J, Yokoe D (2009). Improved Surveillance for Surgical Site Infection Following Orthopedic Implant Procedures: Extending Applications for Automated Data. Clinical Infectious Diseases, 48:1223-9.
  9. Hooper DC, Sands KE, Tully J, Herwaldt LA, Diekema DJ, Wong ES, Climo M, Platt R (2004). Enhanced identification of postoperative infections among inpatients. Emerging Infectious Diseases, 10:1924-1930.
  10. Olsen M, Higham-Kessler J, Yokoe D, Butler A, Stevenson K, Khan Y, Fraser V (2009). Developing a Risk Stratification Model for Surgical Site Infection after abdominal Hysterectomy. Infection Control and Hospital Epidemiology, 30:1077-83.
  11. Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ (2008). Risk factors for surgical site infection following low transverse cesarean section. Infection Control and Hospital Epidemiology, 29(6):477-84.
  12. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VF (2008). Hospital-associated costs due to surgical site infection after breast surgery. Archives of Surgery,143:53-60.
  13. Olsen MA, Krauss M, Agniel D, Schootman M, Gentry CN, Yan Y, Damiano RJ Jr., Fraser VJ (2008). Mortality associated with bloodstream infection following coronary artery bypass surgery. Clinical Infectious Diseases, 46:1537-46.
  14. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield JL, Fraser VJ (2007). Risk factors for surgical site infection following orthopaedic spinal operations. The Journal of Bone and Joint Surgery, 90:62-69. DOI:10.2106/JBJS.F.01515.
  15. Yokoe DS, Noskin GA, Cunningham SM, Zuccotti G, Plaskett T, Fraser VJ, Olsen MA, Tokars N, Solomon S, Perl TM, Cosgrove SE, Tilson RS, Greenbaum M, Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VF (2008). Risk factors for surgical site infection after major breast operation. Journal of the American College of Surgeons, 207:326-35.

Ventilator-associated Pneumonia

  1. Klompas M, Anderson D, Trick W, Babcock H, Kerlin MP, Li L, Sinkowitz-Cochran R, Ely EW, Jernigan J, Magill S, Lyles R, O'Neil C, Kitch BT, Arrington E, Balas MC, Kleinman K, Bruce C, Lankiewicz J, Murphy MV, E Cox C, Lautenbach E, Sexton D, Fraser V, Weinstein RA, Platt R; CDC Prevention Epicenters. The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med. 2015 Feb 1;191(3):292-301.
  2. Lewis SC, Li L, Murphy MV, Klompas M; CDC Prevention Epicenters. Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med. 2014 Aug;42(8):1839-48.
  3. Klompas M, Magill S, Robicsek A, Strymish JM, Kleinman K, Evans RS, Lloyd JF, Khan Y, Yokoe DS, Stevenson K, Samore M, Platt R; CDC Prevention Epicenters Program. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med. 2012 Dec;40(12):3154-61.
  4. Klompas M, Kleinman K, Khan Y, Evans RS, Lloyd JF, Stevenson K, Samore M, Platt R; CDC Prevention Epicenters Program. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis. 2012 Feb 1;54(3):370-7.
  5. Klompas M, Khan Y, Kleinman K, Evans RS, Lloyd JF, Stevenson K, Samore M, Platt R; CDC Prevention Epicenters Program. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One. 2011 Mar 22;6(3):e18062.
  6. Klompas M, Kleinman K, Platt R (2008). Development of an Algorithm for Surveillance of Ventilator-associated Pneumonia With Electronic Data and Comparison of Algorithm Results With Clinician Diagnoses. Infection Control and Hospital Epidemiology, 29(1):31-7.

Antimicrobial Utilization

  1. Han JH, Nachamkin I, Coffin SE, Gerber JS, Fuchs B, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Lautenbach E; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Use of a combination biomarker algorithm to identify medical intensive care unit patients with suspected sepsis at very low likelihood of bacterial infection. Antimicrob Agents Chemother. 2015 Aug 3. pii: AAC.00958-15.
  2. Hamilton KW, Gerber JS, Moehring R, Anderson DJ, Calderwood MS, Han JH, Mehta JM, Pollack LA, Zaoutis T, Srinivasan A, Camins BC, Schwartz DN, Lautenbach E; Centers for Disease Control and Prevention Epicenters Program. Point-of-prescription interventions to improve antimicrobial stewardship. Clin Infect Dis. 2015 Apr 15;60(8):1252-8. doi: 10.1093/cid/civ018. Epub 2015 Jan 16.
  3. Lin M, Weinstein R, and Hota B (2008). Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrobial Agents Chemotherapy, 52(9): 3188-94.
  4. Camins B, King M, Wells J, Googe H, Patel M, Kourbatova E, Blumberg H (2009). Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital: A Randomized Controlled Trial. Infection Control and Hospital Epidemiology, 30(10):931-938.

Previous ID Week Presentations

Current ID Week presentation information can be found on the Prevention Epicenters ID Week Presentations webpage.

ID Week 2014

October 8-12, 2014, in Philadelphia, PA.
  1. Methicillin-Resistant Staphylococcus aureus (MRSA)
  2. Clostridium difficile Infection
  3. Surgical Site Infections
  4. Ventilator-associated Pneumonia
  5. Blood Stream Infections
  6. Technology, Surveillance, and Antimicrobial Stewardship

ID Week 2013

October 2-6, 2013, in San Francisco, California.

ID Week 2012

October 16-21, 2012, in San Diego, California.

Top of page

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #